"Dependovirus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A genus of the family PARVOVIRIDAE, subfamily PARVOVIRINAE, which are dependent on a coinfection with helper adenoviruses or herpesviruses for their efficient replication. The type species is Adeno-associated virus 2.
| Descriptor ID |
D000229
|
| MeSH Number(s) |
B04.280.580.650.170
|
| Concept/Terms |
Adeno-Associated Virus- Adeno-Associated Virus
- Virus, Adeno-Associated
- Viruses, Adeno-Associated
- Adeno-Associated Viruses
|
Below are MeSH descriptors whose meaning is more general than "Dependovirus".
Below are MeSH descriptors whose meaning is more specific than "Dependovirus".
This graph shows the total number of publications written about "Dependovirus" by people in this website by year, and whether "Dependovirus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 1 | 2 |
| 1999 | 2 | 2 | 4 |
| 2000 | 0 | 1 | 1 |
| 2002 | 3 | 1 | 4 |
| 2004 | 1 | 1 | 2 |
| 2005 | 2 | 1 | 3 |
| 2006 | 2 | 0 | 2 |
| 2007 | 2 | 1 | 3 |
| 2008 | 1 | 1 | 2 |
| 2010 | 1 | 1 | 2 |
| 2011 | 1 | 4 | 5 |
| 2012 | 2 | 4 | 6 |
| 2013 | 4 | 1 | 5 |
| 2014 | 3 | 1 | 4 |
| 2015 | 2 | 5 | 7 |
| 2017 | 1 | 4 | 5 |
| 2018 | 0 | 6 | 6 |
| 2019 | 4 | 4 | 8 |
| 2020 | 2 | 3 | 5 |
| 2021 | 2 | 5 | 7 |
| 2022 | 0 | 2 | 2 |
| 2023 | 3 | 4 | 7 |
| 2024 | 3 | 1 | 4 |
| 2025 | 6 | 3 | 9 |
| 2026 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dependovirus" by people in Profiles.
-
Treatment of Huntington's disease with a pan-HTT-targeting CRISPR nuclease. Mol Ther. 2026 08 05; 34(8):4635-4655.
-
Hide-and-Seek genome editing reveals that Gephyrin is required for axo-axonic synapse assembly. Proc Natl Acad Sci U S A. 2025 Aug 12; 122(32):e2500726122.
-
Determinants of successful AAV-vectored delivery of HIV-1 bNAbs in early life. Nature. 2025 09; 645(8082):1020-1028.
-
A comprehensive atlas of AAV tropism in the mouse. Mol Ther. 2025 03 05; 33(3):1282-1299.
-
Suppression of matrigel-induced choroidal neovascularization by AAV delivery of a novel anti-Scg3 antibody. Gene Ther. 2024 11; 31(11-12):587-593.
-
Perimacular Atrophy Following Voretigene Neparvovec-Rzyl Treatment in the Setting of Previous Contralateral Eye Treatment With a Different Viral Vector. Transl Vis Sci Technol. 2024 06 03; 13(6):11.
-
Improved Cardiac Function in Postischemic Rats Using an Optimized Cardiac Reprogramming Cocktail Delivered in a Single Novel Adeno-Associated Virus. Circulation. 2023 10 03; 148(14):1099-1112.
-
Targeting AAV vectors to the central nervous system by engineering capsid-receptor interactions that enable crossing of the blood-brain barrier. PLoS Biol. 2023 07; 21(7):e3002112.
-
Cardiac Myoediting Attenuates Cardiac Abnormalities in Human and Mouse Models of Duchenne Muscular Dystrophy. Circ Res. 2021 09 03; 129(6):602-616.
-
Hepatocyte and stellate cell deletion of liver fatty acid binding protein reveals distinct roles in fibrogenic injury. FASEB J. 2019 03; 33(3):4610-4625.